- /
- Supported exchanges
- / F
- / LIA.F
LivaNova PLC (LIA F) stock market data APIs
LivaNova PLC Financial Data Overview
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LivaNova PLC data using free add-ons & libraries
Get LivaNova PLC Fundamental Data
LivaNova PLC Fundamental data includes:
- Net Revenue: 1 349 M
- EBITDA: 258 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LivaNova PLC News
New
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy LONDON, December 03, 2025--(BUSINESS WIRE)--LivaNova...
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
LONDON, December 02, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization...
A Look at LivaNova's (LIVN) Valuation Following Its Recent 20% Share Price Surge
LivaNova (LIVN) has caught investors’ attention lately as its share price climbed nearly 20% in the past month. This uptick comes amid a steady stream of updates from the medical technology company....
North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED
Company Logo The North America Heart Pump Device market is projected to grow from USD 2.92 billion in 2024 to USD 8.1 billion by 2033, reflecting a CAGR of 12% between 2025-2033. Key drivers include ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.